American Century Companies Inc Agenus Inc Transaction History

American Century Companies Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$2.02 - $3.25 $34,453 - $55,432	17,056 New	17,056 $40,000
Q2 2022 Aug 12, 2022	SELL	$1.3 - $2.64 $297,775 - $604,713	-229,058 Closed	0 $0
Q4 2021 Feb 07, 2022	BUY	$2.92 - $5.74 $668,849 - $1.31 Million	229,058 New	229,058 $738,000
Q2 2021 Aug 05, 2021	SELL	$2.56 - $5.49 $106,690 - $228,801	-41,676 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$2.98 - $5.2 $124,194 - $216,715	41,676 New	41,676 $167,000
Q4 2019 Feb 12, 2020	SELL	$2.41 - $4.4 $80,660 - $147,263	-33,469 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$2.17 - $3.14 $72,627 - $105,092	33,469 New	33,469 $86,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

Stay updated on American Century Companies Inc with notifications on news.